johnson
Few in NHS trust tech firms handling patient data
November 29, 2019Medical Communications AI, Boris, Corbyn, NHS, NHS Brexit, johnson
Few in the NHS trust ‘big tech’ companies to handle patient data in a confidential manner, a recent YouGov poll …
J&J hands over compassionate use reviews to academics
May 7, 2015Sales and Marketing J&J, JJ, academics, compac, eap, johnson
Johnson & Johnson has struck a ‘first-of-its-kind partnership’ with academic researchers to review requests for compassionate use of its investigational …
Gilead expands UK presence with new London HQ
February 10, 2015Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge
Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …
J&J leukaemia drug gets FDA go-ahead
January 30, 2015Sales and Marketing FDA, J&J, JJ, Janssen, The US Food and Drug Administration has shown Janssen’s leukaemia drug Imbruvica the green light to treat patients with waldenström’s macroglobulinemia (WM) – a rare indol, Waldenström’s Macroglobulinemia, ibrutinab, imbruvica, johnson
The US Food and Drug Administration has shown Janssen’s leukaemia drug Imbruvica the green light to treat patients with waldenström’s …
Vectura and J&J shake on asthma/COPD deal
January 6, 2015Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura
British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …
UK nurse with Ebola in ‘critical condition’
January 6, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp
A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …
GSK Ebola vaccine gets EU support
December 17, 2014Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson
A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …
Dendreon files for bankruptcy
November 12, 2014Research and Development, Sales and Marketing Dendreon, Provenge, awick, delaware, johnson, nj
Dendreon Corporation, the troubled manufacturer of high-cost cancer vaccine Provenge, has filed for bankruptcy as a prelude to restructuring its …
J&J announces ‘major commitment’ to Ebola effort
October 22, 2014Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid
Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …
GSK Ebola vaccine underway
August 11, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Vaccine, WHO, johnson
Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline. The …
MediCity hub moves forward
June 11, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BioCity, alderley park, johnson, medcity, medicity
Nine new businesses have signed tenancy agreements at Nottingham’s MediCity, bringing to 20 the number of companies which have been …
New biomedical engineering centre for Imperial
May 28, 2014Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, imperial college london, johnson, medcity, uren
Imperial College London is to build a pioneering biomedical engineering centre that will cement London and the south east’s reputation …
NICE: no early Zytiga use
May 14, 2014Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate
Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …
Major new launches for 2014
March 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10
AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …
J&J reveals more on transparency policy
February 3, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda
Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …
Latest content
FibroFind appoints Lee Borthwick as CEO
